Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

RGS6 Inhibitors

The chemical class known as RGS6 inhibitors encompasses a diverse array of organic compounds distinguished by their unique molecular structures and their capacity to selectively interact with specific components of the Regulator of G protein Signaling 6 (RGS6) protein. RGS6 plays a critical role in modulating intracellular signaling pathways, particularly those mediated by G protein-coupled receptors (GPCRs). The development of RGS6 inhibitors is rooted in a deep understanding of the intricate biochemical pathways involving RGS6, which contributes to the fine-tuning of cellular responses. RGS6 inhibitors are thoughtfully designed through a combination of rational drug design strategies and empirical experimentation. Researchers employ advanced techniques to engineer the structural attributes of these inhibitors, enabling them to selectively bind to distinct regions of RGS6 or its associated partners. This selective binding capability empowers RGS6 inhibitors to modulate the activity of RGS6, thereby influencing the complex molecular events that RGS6 regulates, including GPCR-mediated signaling cascades.

The chemical structures of RGS6 inhibitors exhibit remarkable diversity, reflecting the intricate nature of RGS6 and its multifaceted interactions within cellular pathways. The design of RGS6 inhibitors benefits from insights gleaned from structural biology, computational modeling, and detailed biochemical analyses. By meticulously probing the molecular interactions involving RGS6, researchers can strategically design inhibitors with tailored attributes that selectively interfere with RGS6-associated processes. RGS6 inhibitors represent invaluable tools for advancing scientific knowledge in the field of intracellular signaling modulation. By perturbing RGS6-mediated pathways, these inhibitors empower researchers to delve into the intricate web of molecular events underpinning cellular responses, particularly those mediated by GPCRs. The development of RGS6 inhibitors exemplifies the ongoing dedication to unraveling the nuanced roles of RGS6 in cellular physiology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

CCG 203971

1443437-74-8sc-507360
10 mg
$89.00
(0)

CCG-203971 is a small molecule inhibitor that has been studied for its potential to inhibit the interaction between RGS6 and certain GPCRs, affecting GPCR signaling pathways.

Xanthohumol from hop (Humulus lupulus)

6754-58-1sc-301982
5 mg
$361.00
1
(0)

Xanthohumol is a natural compound found in hops that has been investigated for its effects on RGSIt may modulate GPCR signaling pathways through interactions with RGS6.

BIX01294 hydrochloride

1392399-03-9sc-293525
sc-293525A
sc-293525B
1 mg
5 mg
25 mg
$37.00
$112.00
$408.00
(1)

BIX-01294 is a known inhibitor of lysine methyltransferases, but it has also been explored for its potential to inhibit RGS6 and affect GPCR signaling pathways.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin is a flavonoid that has been studied for its potential effects on RGSIt may modulate GPCR-mediated cellular responses through interactions with RGS6.